Human Intestinal Organoids Recapitulate Enteric Infections of Enterovirus and Coronavirus.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
09 03 2021
Historique:
received: 18 12 2020
revised: 09 02 2021
accepted: 09 02 2021
pubmed: 25 2 2021
medline: 25 3 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

Enteroviruses, such as EV-A71 and CVA16, mainly infect the human gastrointestinal tract. Human coronaviruses, including SARS-CoV and SARS-CoV-2, have been variably associated with gastrointestinal symptoms. We aimed to optimize the human intestinal organoids and hypothesize that these optimized intestinal organoids can recapitulate enteric infections of enterovirus and coronavirus. We demonstrate that the optimized human intestinal organoids enable better simulation of the native human intestinal epithelium, and that they are significantly more susceptible to EV-A71 than CVA16. Higher replication of EV-A71 than CVA16 in the intestinal organoids triggers a more vigorous cellular response. However, SARS-CoV and SARS-CoV-2 exhibit distinct dynamics of virus-host interaction; more robust propagation of SARS-CoV triggers minimal cellular response, whereas, SARS-CoV-2 exhibits lower replication capacity but elicits a moderate cellular response. Taken together, the disparate profile of the virus-host interaction of enteroviruses and coronaviruses in human intestinal organoids may unravel the cellular basis of the distinct pathogenicity of these viral pathogens.

Identifiants

pubmed: 33626333
pii: S2213-6711(21)00089-8
doi: 10.1016/j.stemcr.2021.02.009
pmc: PMC7940440
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-504

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Science. 2015 Jan 16;347(6219):269-73
pubmed: 25431489
Epidemiol Infect. 2010 Aug;138(8):1071-89
pubmed: 20056019
J Infect Dis. 2014 May 1;209(9):1331-42
pubmed: 24065148
Pediatrics. 2007 Aug;120(2):e244-52
pubmed: 17671037
Cell Rep. 2019 Feb 26;26(9):2509-2520.e4
pubmed: 30811997
Nature. 2017 May 11;545(7653):238-242
pubmed: 28467820
Nat Rev Immunol. 2005 Dec;5(12):917-27
pubmed: 16322745
Lancet Infect Dis. 2014 Apr;14(4):308-318
pubmed: 24485991
Gastroenterology. 2003 Oct;125(4):1011-7
pubmed: 14517783
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7944-9
pubmed: 21518880
J Clin Invest. 2018 Nov 1;128(11):5163-5177
pubmed: 30153112
Science. 2016 Sep 23;353(6306):1387-1393
pubmed: 27562956
Pediatr Rev. 1998 Jun;19(6):183-91
pubmed: 9613170
Nat Microbiol. 2018 Jul;3(7):814-823
pubmed: 29946163
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Commun. 2017 Jan 06;8:13824
pubmed: 28059064
Antiviral Res. 2019 Jan;161:125-133
pubmed: 30503888
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
EMBO Mol Med. 2019 Jan;11(1):
pubmed: 30498026
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Nat Immunol. 2015 Aug;16(8):802-9
pubmed: 26194286
J Pathol. 2015 Jan;235(2):217-28
pubmed: 25211036
Lancet Infect Dis. 2010 Nov;10(11):778-90
pubmed: 20961813
Am J Anat. 1974 Dec;141(4):461-79
pubmed: 4440632
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Sci Adv. 2017 Nov 15;3(11):eaao4966
pubmed: 29152574
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6822-6827
pubmed: 29891677
Nat Genet. 2004 Oct;36(10):1117-21
pubmed: 15378062
J Med Virol. 2020 Oct;92(10):1834-1844
pubmed: 32462689
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Genes Dev. 2014 Feb 15;28(4):305-16
pubmed: 24532711
Sci Adv. 2019 Mar 06;5(3):eaau4255
pubmed: 30854425

Auteurs

Xiaoyu Zhao (X)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Cun Li (C)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Xiaojuan Liu (X)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Man Chun Chiu (MC)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Dong Wang (D)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Yuxuan Wei (Y)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Hin Chu (H)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Jian-Piao Cai (JP)

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China.

Ivy Hau-Yee Chan (I)

Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Kenneth Kak-Yuen Wong (K)

Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Jasper Fuk-Woo Chan (J)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China; Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong, China.

Kelvin Kai-Wang To (K)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China; Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong, China.

Kwok Yung Yuen (KY)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China; Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong, China.

Jie Zhou (J)

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong, China. Electronic address: jiezhou@hku.hk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH